Dilatation as a Marker of Pulmonary Veins Initiating Atrial Fibrillation
Teiichi Yamane(Jikei University School of Medicine), Michel Haı̈ssaguerre(Hôpital Cardiologique du Haut-Lévêque), Pierre Jaı̈s(Montreal Heart Institute), Jacques Clémenty(Hôpital Cardiologique du Haut-Lévêque), Mélèze Hocini(Electrophysiology and Heart Modeling Institute), Isabel Deisenhofer(Deutsches Herzzentrum München), Jing Peng(Hôpital Cardiologique du Haut-Lévêque), Dipen Shah(Hôpital Cardiologique du Haut-Lévêque)
Cited by 64
Related Papers
Electrophysiological Breakthroughs From the Left Atrium to the Pulmonary Veins
|Circulation|2000|966
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation
|Circulation|2008|887
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device
|Circulation|2016|855
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
|New England Journal of Medicine|2008|763